Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Harvard Business School
Express Scripts
Mallinckrodt
AstraZeneca

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Technetium tc-99m pyrophosphate kit - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for technetium tc-99m pyrophosphate kit and what is the scope of patent protection?

Technetium tc-99m pyrophosphate kit is the generic ingredient in three branded drugs marketed by Pharmalucence, Bracco, and Curium, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m pyrophosphate kit. Two suppliers are listed for this compound.

Summary for technetium tc-99m pyrophosphate kit
Recent Clinical Trials for technetium tc-99m pyrophosphate kit

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Brigham and Women's HospitalPhase 2

See all technetium tc-99m pyrophosphate kit clinical trials

Pharmacology for technetium tc-99m pyrophosphate kit

US Patents and Regulatory Information for technetium tc-99m pyrophosphate kit

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco PHOSPHOTEC technetium tc-99m pyrophosphate kit INJECTABLE;INJECTION 017680-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Curium TECHNESCAN PYP KIT technetium tc-99m pyrophosphate kit INJECTABLE;INJECTION 017538-001 Approved Prior to Jan 1, 1982 AP RX No No   Start Trial   Start Trial   Start Trial
Pharmalucence CIS-PYRO technetium tc-99m pyrophosphate kit INJECTABLE;INJECTION 019039-001 Jun 30, 1987 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Harvard Business School
Express Scripts
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.